At Gateway, it is always and only about the patient
Gateway for Cancer Research has taken this commitment to the next level by integrating patient centricity into every level of decision-making. Researchers are incentivized to adopt outcomes that place patients at the center of their work. Patient representatives sit at every level of the Gateway organization, up to and including the Board of Directors.
Never again am I going to look at a birthday and say ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad I’m going to be another year older!’
Gateway is an experienced investor in early phase cancer research.
As careful stewards of donor dollars, Gateway monitors trends in the field of oncology, only funding the most innovative and impactful approaches.
Your dollar has the most impact with Gateway.
100 % of every dollar donated to Gateway directly funds research thanks to the generous underwriting from the Stephenson Family.
Gateway partners with renowned research institutions around the world.
These partnerships enable leading clinician-scientists and their promising ideas for new cancer drugs and approaches to be evaluated with support from Gateway.
Gateway only funds clinical trials with the potential to forever change the face of cancer care.
The Phase I and Phase II trials Gateway funds are instrumental in bringing new treatments and therapies to the bedside of today’s cancer patients.
Did You Know?
234 clinical trials have been funded worldwide by Gateway since 1991.
For Liesel, a Gateway-funded clinical trial offered hope for the future after being diagnosed with a brain tumor while in high school.
Liesel participated in a research study being led by Sarah Leary, MD at Seattle Children’s Hospital investigating the safety of ‘tumor paint’, which illuminates the tumor during brain surgery allowing healthy tissue to be spared, helping to make brain surgery more effective. Using Dr. Leary’s innovative ‘tumor paint’ surgeons successfully removed Liesel’s tumor without causing irreversible damage to her brain.
It costs just $19.62 per patient per day in a Gateway-funded cancer clinical trial.
Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniversary, birthday, wedding, bar/bat mitzvah or graduation.
